EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $127,000 | -75.9% | 86,478 | -81.1% | 0.00% | -100.0% |
| Q1 2022 | $526,000 | +1043.5% | 457,670 | +2408.7% | 0.00% | – |
| Q4 2021 | $46,000 | -93.8% | 18,243 | -70.5% | 0.00% | -100.0% |
| Q3 2020 | $738,000 | -59.8% | 61,825 | -45.9% | 0.00% | -66.7% |
| Q2 2020 | $1,834,000 | -3.5% | 114,206 | -6.8% | 0.00% | 0.0% |
| Q1 2020 | $1,901,000 | +103.5% | 122,559 | +222.7% | 0.00% | +200.0% |
| Q4 2019 | $934,000 | +665.6% | 37,984 | +220.0% | 0.00% | – |
| Q3 2019 | $122,000 | -58.5% | 11,870 | -49.3% | 0.00% | – |
| Q2 2019 | $294,000 | +11.4% | 23,425 | +57.3% | 0.00% | – |
| Q1 2018 | $264,000 | -24.6% | 14,894 | -46.6% | 0.00% | – |
| Q4 2017 | $350,000 | -43.8% | 27,874 | -14.7% | 0.00% | -100.0% |
| Q3 2017 | $623,000 | +59.3% | 32,692 | +26.3% | 0.00% | 0.0% |
| Q2 2017 | $391,000 | – | 25,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |